Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Helseth

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Human Gene Therapy|May 26, 2019
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 TherapyYuefeng Yang, Weidong Xu, Di Peng, et al.
Frontiers in Genetics|December 13, 2023
Personalized medicine in a community health system: the NorthShore experienceSean P David, Henry M Dunnenberger, Sarah Choi, et al.
Cancers|February 13, 2026
Operationalizing Next-Generation Sequencing in a Community-Based Academic Cancer Center: Workflow, Integration, and ImpactGayathri Moorthy, Annette Sereika, Bruce Brockstein, et al.
European Urology|December 20, 2016
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathRong Na, S Lilly Zheng, Misop Han, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
On the safety of 5-[125I]iodo-2'-deoxyuridine--Preclinical evaluation in swineJ Baranowska-Kortylewicz, G V Dalrymple, K A Harrison, et al.
Human Gene Therapy|May 26, 2019
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 TherapyYuefeng Yang, Weidong Xu, Di Peng, et al.
Frontiers in Genetics|December 13, 2023
Personalized medicine in a community health system: the NorthShore experienceSean P David, Henry M Dunnenberger, Sarah Choi, et al.
Cancers|February 13, 2026
Operationalizing Next-Generation Sequencing in a Community-Based Academic Cancer Center: Workflow, Integration, and ImpactGayathri Moorthy, Annette Sereika, Bruce Brockstein, et al.
European Urology|December 20, 2016
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathRong Na, S Lilly Zheng, Misop Han, et al.
Pageof 3